Serum 25-hydroxyvitamin D Concentration and Risk for Major Clinical Disease Events in a Community-based Population of Older Adults: a Cohort Study
Overview
Authors
Affiliations
Background: Circulating concentrations of 25-hydroxyvitamin D [25-(OH)D] are used to define vitamin D deficiency. Current clinical 25-(OH)D targets based on associations with intermediate markers of bone metabolism may not reflect optimal levels for other chronic diseases and do not account for known seasonal variation in 25-(OH)D concentration.
Objective: To evaluate the relationship of 25-(OH)D concentration with the incidence of major clinical disease events that are pathophysiologically relevant to vitamin D.
Design: Cohort study.
Setting: The Cardiovascular Health Study conducted in 4 U.S. communities. Data from 1992 to 2006 were included in this analysis.
Participants: 1621 white older adults.
Measurements: Serum 25-(OH)D concentration (using a high-performance liquid chromatography-tandem mass spectrometry assay that conforms to National Institute of Standards and Technology reference standards) and associations with time to a composite outcome of incident hip fracture, myocardial infarction, cancer, or death.
Results: Over a median 11-year follow-up, the composite outcome occurred in 1018 participants (63%). Defining events included 137 hip fractures, 186 myocardial infarctions, 335 incidences of cancer, and 360 deaths. The association of low 25-(OH)D concentration with risk for the composite outcome varied by season (P = 0.057). A concentration lower than a season-specific Z score of -0.54 best discriminated risk for the composite outcome and was associated with a 24% higher risk in adjusted analyses (95% CI, 9% to 42%). Corresponding season-specific 25-(OH)D concentrations were 43, 50, 61, and 55 nmol/L (17, 20, 24, and 22 ng/mL) in winter, spring, summer, and autumn, respectively.
Limitation: The observational study was restricted to white participants.
Conclusion: Threshold concentrations of 25-(OH)D associated with increased risk for relevant clinical disease events center near 50 nmol/L (20 ng/mL). Season-specific targets for 25-(OH)D concentration may be more appropriate than static targets when evaluating health risk.
Primary Funding Source: National Institutes of Health.
Dhaher N, Wandell P, Bennet L J Diabetes Metab Disord. 2024; 24(1):15.
PMID: 39712337 PMC: 11659546. DOI: 10.1007/s40200-024-01543-y.
Katagiri R, Goto A, Nakano S, Nakatochi M, Koyanagi Y, Iwagami M Sci Rep. 2023; 13(1):2384.
PMID: 36765195 PMC: 9918529. DOI: 10.1038/s41598-023-29596-8.
Ghahfarrokhi S, Mohammadian-Hafshejani A, Sherwin C, Heidari-Soureshjani S J Bone Miner Metab. 2022; 40(4):541-553.
PMID: 35639176 DOI: 10.1007/s00774-022-01333-7.
Geng J, Qiu Y, Li Y, Li J, Liao R, Du H Front Nutr. 2022; 8:716878.
PMID: 35242790 PMC: 8885514. DOI: 10.3389/fnut.2021.716878.
Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System.
Zhang S, Miller D, Li W Int J Mol Sci. 2021; 22(4).
PMID: 33669918 PMC: 7924658. DOI: 10.3390/ijms22042128.